# US 2021/0010040 A1 · D-Lactate Dehydrogenase, Engineered Strain Containing D-Lactate Dehydrogenase and Construction Method and Use of Engineered Strain

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0010040 A1
- Document ID: US20210010040A1
- Status: Published application
- Kind: A1
- Application number: 16/910,127
- Filed: 2020-06-24
- Published: 2021-01-14
- Earliest claimed: 2016-01-27
- Assignees: Shanghai Jiao Tong University
- Applicants: Shanghai Jiao Tong University
- Inventors: Ping Xu; Chao Li; Fei Tao; Hongzhi Tang
- Web page: https://patentgrep.com/patent/US20210010040A1

## CPC

- C12P 7/56: Lactic acid
- C12N 9/0006: {acting on CH-OH groups as donors (1.1)}
- C12N 9/1022: {transferring aldehyde or ketonic groups (2.2)}
- C12N 15/75: for Bacillus
- C12Y 101/01028: D-Lactate dehydrogenase (1.1.1.28)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

The present invention provides D-lactate dehydrogenase, an engineered strain containing the D-lactate dehydrogenase and a construction method and use of the engineered strain. The present invention discloses a D-lactate dehydrogenase which has unique properties and is from Thermodesulfatator indicus, and the D-lactate dehydrogenase has good thermophily and heat stability. By using the D-lactate dehydrogenase and said gene engineering reconstruction method, a fermentation product of the reconstructed Bacillus licheniformis can be redirected to optically-pure D-lactic acid with a high yield from naturally produced 2,3-butanediol, and the optical purity of the produced D-lactic acid reaches 99.9%; and raw materials for fermentation are low-cost, and a fermentation state is between an anaerobic fermentation state and a microaerobic fermentation state. By using the inventive method for producing D-lactic acid through fermentation at high temperature, the production cost can be reduced, the production efficiency can be improved and there is a wide industrial application prospect for the inventive method.

## Claims

### Claim 1

A nucleotide sequence, wherein the nucleotide sequence codes a D-lactate dehydrogenase comprising a substitution, deletion, insertion, addition of one or more amino acid residues, wherein said D-lactate dehydrogenase comprises an amino acid sequence having at least 80% and less than 100% sequence identity to SEQ ID No.1, and wherein said D-lactate dehydrogenase has D-lactate dehydrogenase activity.

### Claim 2 (depends on 1)

The nucleotide sequence according to claim 1, wherein the nucleotide sequence is one of the following nucleotide sequences:
1) a nucleotide sequence of SEQ ID No.2;
2) a nucleotide sequence of SEQ ID No.3;
3) a nucleotide sequence having more than 80% of homology with the nucleotide sequence of SEQ ID No.2 or SEQ ID No.3; and
4) a nucleotide sequence hybridized with a complementary chain of the nucleotide sequence of SEQ ID No.2 or SEQ ID No.3 under a high-stringency condition.

### Claim 3

Use of a D-lactate dehydrogenase in production of D-lactic acid, wherein said D-lactate dehydrogenase comprises a substitution, deletion, insertion, addition of one or more amino acid residues, wherein said D-lactate dehydrogenase comprises an amino acid sequence having at least 80% and less than 100% sequence identity to SEQ ID No.1, and wherein said D-lactate dehydrogenase has D-lactate dehydrogenase activity.

### Claim 4 (depends on 3)

The use according to claim 3, wherein a nucleotide sequence encoding the D-lactate dehydrogenase is one of the following nucleotide sequences:
1) a nucleotide sequence of SEQ ID No.2;
2) a nucleotide sequence of SEQ ID No.3;
3) a nucleotide sequence having more than 80% of homology with the nucleotide sequence of SEQ ID No.2 or SEQ ID No.3; and
4) a nucleotide sequence hybridized with a complementary chain of the nucleotide sequence of SEQ ID No.2 or SEQ ID No.3 under a high-stringency condition.

### Claim 5

A gene engineering strain, wherein the gene engineering strain has a D-lactate dehydrogenase, wherein said D-lactate dehydrogenase comprises a substitution, deletion, insertion, addition of one or more amino acid residues, wherein said D-lactate dehydrogenase comprises an amino acid sequence having at least 80% and less than 100% sequence identity to SEQ ID No.1, and wherein said D-lactate dehydrogenase has D-lactate dehydrogenase activity.

### Claim 6 (depends on 5)

The gene engineering strain according to claim 5, wherein a nucleotide sequence encoding the D-lactate dehydrogenase is one of the following nucleotide sequences:
1) a nucleotide sequence of SEQ ID No.2;
2) a nucleotide sequence of SEQ ID No.3;
3) a nucleotide sequence having more than 80% of homology with the nucleotide sequence of SEQ ID No.2 or SEQ ID No.3; and
4) a nucleotide sequence hybridized with a complementary chain of the nucleotide sequence of SEQ ID No.2 or SEQ ID No.3 under a high-stringency condition.

### Claim 7 (depends on 5)

The gene engineering strain according to claim 5, wherein in the gene engineering strain, a pathway for synthesizing L-lactic acid by pyruvic acid is blocked and a pathway for synthesizing 2,3-butanediol by pyruvic acid is blocked.

### Claim 8 (depends on 7)

The gene engineering strain according to claim 7, wherein the pathway for synthesizing L-lactic acid by pyruvic acid is blocked by deactivating or deleting an L-lactate dehydrogenase gene; and the pathway for synthesizing 2,3-butanediol by pyruvic acid is blocked by deactivating or deleting one or both of an acetolactate synthase gene and an acetolactate decarboxylase gene.

### Claim 9 (depends on 7)

The gene engineering strain according to claim 7, wherein in the gene engineering strain, one or more of a pathway for synthesizing formic acid by pyruvic acid, a pathway for synthesizing acetic acid by pyruvic acid and a pathway for synthesizing ethanol by pyruvic acid are blocked.

### Claim 10 (depends on 9)

The gene engineering strain according to claim 9, wherein the pathway for synthesizing formic acid by pyruvic acid is blocked by deactivating or deleting one or both of a pyruvate formate-lyase gene and a pyruvate formate-lyase activating enzyme gene; the pathway for synthesizing acetic acid by pyruvic acid is blocked by deactivating or deleting one or both of a pyruvate dehydrogenase gene and an acetokinase gene; and the pathway for synthesizing ethanol by pyruvic acid is blocked by deactivating or deleting one or both of a pyruvate dehydrogenase gene and an ethanol dehydrogenase gene.

### Claim 11 (depends on 7)

The gene engineering strain according to claim 7, wherein an original D-lactate dehydrogenase gene in the gene engineering strain is deactivated or deleted.

### Claim 12 (depends on 7)

The gene engineering strain according to claim 7, wherein an original strain of the gene engineering strain is thermophilus.

### Claim 13 (depends on 7)

The gene engineering strain according to claim 7, wherein an original strain of the gene engineering strain is bacillus.

### Claim 14 (depends on 13)

The gene engineering strain according to claim 13, wherein the bacillus is selected from a group consisting of Bacillus licheniformis, Bacillus coagulans, B. subtilis, Bacillus amyloliquefaciens, Bacillus pumilus, Bacillus circulans and Aneurinibacillus aneurinilyticus.

### Claim 15 (depends on 12)

The gene engineering strain according to claim 12, wherein a restrictive modification system in the original strain is deactivated or knocked out.

### Claim 16 (depends on 15)

The gene engineering strain according to claim 15, wherein the original strain is a ΔhsdR1ΔhsdR2 double-mutant strain MW3 of Bacillus licheniformis ATCC 14580.

### Claim 17 (depends on 12)

The gene engineering strain according to claim 12, wherein a promoter of a coding gene of the D-lactate dehydrogenase is reconstructed into a constitutive promoter.

### Claim 18 (depends on 17)

The gene engineering strain according to claim 17, wherein the constitutive promoter is a promoter Pals of α-acetolactate synthase of Bacillus licheniformis ATCC 14580, a Pc promoter in plasmid pMMPc, a P43 promoter in B. subtilis or a promoter Pklh of L-lactate dehydrogenase of Bacillus licheniformis ATCC 14580.

### Claim 19 (depends on 17)

The gene engineering strain according to claim 17, wherein the constitutive promoter is a promoter Pals of α-acetolactate synthase of Bacillus licheniformis ATCC 14580.

### Claim 20 (depends on 5)

The gene engineering strain according to claim 5, wherein the gene engineering strain is Bacillus licheniformis BN11, the preservation number of which is CCTCC NO: M2016026 and which was preserved in China Center for Type Culture Collection on Jan. 8, 2016.

### Claim 21 (depends on 5)

A method for preparing the gene engineering strain according to claim 5, wherein the method comprises: deactivating or deleting an L-lactate dehydrogenase gene in an original strain; and introducing a nucleotide sequence encoding the D-lactate dehydrogenase.

### Claim 22 (depends on 21)

The method according to claim 21, wherein the nucleotide sequence encoding the D-lactate dehydrogenase is one of the following nucleotide sequences:
1) a nucleotide sequence of SEQ ID No.2;
2) a nucleotide sequence of SEQ ID No.3;
3) a nucleotide sequence having more than 80% of homology with the nucleotide sequence of SEQ ID No.2 or SEQ ID No.3; and
4) a nucleotide sequence hybridized with a complementary chain of the nucleotide sequence of SEQ ID No.2 or SEQ ID No.3 under a high-stringency condition.

### Claim 23 (depends on 21)

The method according to claim 21, wherein the method further comprises: deactivating or deleting an original D-lactate dehydrogenase gene in the original strain; and blocking a pathway for synthesizing 2,3-butanediol by pyruvic acid.

### Claim 24 (depends on 23)

The method according to claim 23, wherein the method further comprises: reconstructing a promoter of the introduced nucleotide sequence into a constitutive promoter.

### Claim 25 (depends on 24)

The method according to claim 24, wherein the original strain is a ΔhsdR1ΔhsdR2 double-mutant strain MW3 of Bacillus licheniformis ATCC 14580; and α-acetolactate decarboxylase (alsD) and acetolactate synthase (alsS) genes are replaced with the nucleotide sequence encoding the D-lactate dehydrogenase.

### Claim 26 (depends on 5)

Use of the gene engineering strain according to claim 5 in production of D-lactic acid.

### Claim 27 (depends on 26)

The use according to claim 26, wherein a carbon source adopted in the production is one or more selected from a group consisting of glucose, xylose, maltose, lactose and sucrose.

### Claim 28 (depends on 26)

The use according to claim 26, wherein low-price culture mediums containing peanut meal or dried corn steep liquor powder are adopted for fermentation in the production.

### Claim 29 (depends on 26)

The use according to claim 26, wherein fermentation temperature for the production is 45° C.-55° C.

### Claim 30 (depends on 29)

The use according to claim 29, wherein pH of the fermentation culture mediums for the production is 6.0-8.0.

### Claim 31 (depends on 26)

The use according to claim 26, wherein a fermentation process for the production is a continuous fermentation or fed-batch process.
